Article Details

Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License ...

Retrieved on: 2021-07-02 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License .... View article details on hiswai:

Excerpt

Under the terms of the agreement, Nestlé Health Science will utilize its global pharmaceutical business Aimmune Therapeutics and will assume the ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up